SANDOZ GROUP AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.72 CHF | +0.62% |
|
+1.31% | +17.22% |
| Jun. 07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
| May. 22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Sales forecast by analysts have been recently revised upwards.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
Ratings chart - Surperformance
Sector: Pharmaceuticals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +17.22% | 15.07B | - | ||
| +19.64% | 43.03B | B- | ||
| +23.86% | 22.7B | B+ | ||
| +23.64% | 14.77B | B+ | ||
| +59.16% | 13.05B | B | ||
| -0.05% | 6.79B | - | - | |
| -14.19% | 6.58B | B+ | ||
| -8.87% | 5.73B | - | - | |
| +13.42% | 5.5B | B+ | ||
| +5.66% | 4.59B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
-
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- SDZ Stock
- Ratings Sandoz Group AG
